MiNK Therapeutics, Inc. (INKT) Operating cash flow 2020–2025
MiNK Therapeutics, Inc. (INKT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.9MFY2025 · since FY2020: -$8.3M → -$5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.9M | +38.0% |
| FY2024 | -$9.6M | +39.4% |
| FY2023 | -$15.8M | +16.5% |
| FY2022 | -$18.9M | -47.1% |
| FY2021 | -$12.8M | -53.8% |
| FY2020 | -$8.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INKT financial trends
INKT RevenueINKT Net incomeINKT Net marginINKT Gross profitINKT Gross marginINKT Operating incomeINKT Operating marginINKT Free cash flowINKT Capital expendituresINKT Return on equityINKT Stock buybacksINKT Dividends paidINKT Total assetsINKT Total liabilitiesINKT Shareholders’ equityINKT overview →